Skip to main content

and
  1. Article

    9.9 Aliskiren, a Novel Renin Inhibitor, is Well Tolerated and Has Sustained BP-Lowering Effects Alone or in Combination with HCTZ During Long-Term (52 Weeks) Treatment of Hypertension

    M. Destro, D. Sica, A. Gradman in High Blood Pressure & Cardiovascular Preve… (2007)